arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Dominari Holdings Inc.

DOMH Health Care Biotechnology: Pharmaceutical Preparations
$2.83
Today
as of Jul 22, 16:48 ET
Last 30 days -10.44% Jun 12 → Jul 22
$2.71 $2.89 $3.06 $3.24 $3.42 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$3.26
High
$3.28
Low
$3.00
Volume
$279,385
Avg Vol
$238,319
Mkt Cap
$63M
P/E (TTM)
0.59
Beta
—
52w High
$8.40
52w Low
$2.69
Div Yield
—
Shares Out
$23M

Recent Press Releases & News last 60 days · 1 item

Jun 15 · 12:00 PR PR Newswire
Dominari Securities Raises $200,000,000.00 in World's Largest IPO

Overview

52-week range
$2.69
$8.40
2% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+0.9%
50% positive
Latest IV / EM
124%
EM ±28.3% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.17$-0.56$2.05$4.66$7.27 Actual $-1.79Actual $-0.66Actual $-0.91Actual $-1.01Actual $-0.67Actual $-3.02Actual $-1.02Actual $7.27Actual $-3.17 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-57M$-10M$37M$84M$131M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-3.17 — — -5.0% +3.7% earnings
Tue Sep 30, 2025Sep 2025 $7.27 — — — — financials
Mon Aug 11, 2025Jun/2025 $-1.02 — — — — earnings
Mon May 12, 2025Mar/2025 $-3.02 — — — -2.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.67 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.01 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.91 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.66 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.79 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Aug 10, 2026Jun/2026OTHER —-$1.02

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$36M—$51M$34M$7M—$4M$6M
Cost of revenue————————
Gross profit————————
Operating income$-38M—$-2M$-19M$-33M—$-3M$-3M
Net income$-57M—$125M$17M$-32M—$-4M$-6M
EPS (diluted)$-3.17—$7.27$1.12$-3.02—$-0.67$-1.01

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$27M$34M$5M$9M$6M$4M$3M$6M
Inventory————————
Total current assets——$206M$60M$35M$28M$25M$29M
Total assets$85M$113M$223M$109M$52M$47M$43M$49M
Long-term debt————————
Total liabilities$54M$44M$13M$21M$10M$7M$5M$7M
Total equity$32M$69M$210M—$42M$40M$38M$42M

Implied volatility — last 90 days

123%672%1221%1769%2318% Jun 07 — IV 378% · EM ±52.4%Jun 08 — IV 400% · EM ±52.8%Jun 09 — IV 724% · EM ±90.8%Jun 10 — IV 841% · EM ±99.4%Jun 11 — IV 863% · EM ±95.3%Jun 12 — IV 959% · EM ±98.1%Jun 15 — IV 912% · EM ±66.0%Jun 16 — IV 1190% · EM ±70.3%Jun 17 — IV 2318% · EM ±96.8%Jun 19 — IV 275% · EM ±60.8%Jun 22 — IV 287% · EM ±59.9%Jun 23 — IV 363% · EM ±74.3%Jun 24 — IV 261% · EM ±52.3%Jun 25 — IV 317% · EM ±62.1%Jun 29 — IV 307% · EM ±54.3%Jun 30 — IV 435% · EM ±74.8%Jul 01 — IV 432% · EM ±72.1%Jul 02 — IV 305% · EM ±49.3%Jul 03 — IV 316% · EM ±49.3%Jul 06 — IV 394% · EM ±54.6%Jul 07 — IV 379% · EM ±50.0%Jul 08 — IV 336% · EM ±42.1%Jul 09 — IV 423% · EM ±50.0%Jul 10 — IV 240% · EM ±26.5%Jul 13 — IV 579% · EM ±48.4%Jul 14 — IV 713% · EM ±51.6%Jul 15 — IV 759% · EM ±44.8%Jul 16 — IV 1193% · EM ±49.8%Jul 20 — IV 219% · EM ±51.8%Jul 21 — IV 220% · EM ±51.1%Jul 22 — IV 124% · EM ±28.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in